Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

National Hospital Organization - Osaka General Hospital

     
Osaka , 540-0006
Japan

 

Principal Investigator:
Toshimasa Tsujinaka, MD
Contact:
Toshimasa Tsujinaka, MD +81 6 6942 1331 toshi@onh.go.jp
Activation Status of this Site:
Closed
Notes about this Site:
National Hospital Organization - Osaka General Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.